New shot could tame peanut allergies in one dose
Disease control
Completed
This early-stage trial tested a single injection of a new drug called IGNX001 in 32 adults and teens with peanut allergies. The main goal was to check safety and how the body processes the drug. Participants received either the drug or a placebo, and researchers monitored for sid…
Phase: PHASE1 • Sponsor: IgGenix Australia Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC